2001, Compliance and World Health - Health Care Compliance Brief

SQA Regulatory Surveillance Summary 3 | Monthly Update 2021

SQA

APRIL 30, 2021

In addition, considering the fact that one marketing authorization application is submitted in accordance with Article 8(3) of Directive 2001/83/EC and the other marketing authorization application is submitted under an abridged procedure (e.g., World Health Organization (WHO). European Medicines Agency (EMA) – Biologics.

COVID-19 Vaccine

COVID-19 Vaccine COVID-19 Compliance Governance

SQA Regulatory Surveillance Summary | Monthly Update 2022 – September/October

SQA

DECEMBER 16, 2022

ANVISA announced major updates to its Resolution of the Collegiate Board of Directors (RDC) 185/2001. China’s Center for Medical Device Evaluation (CMDE) Update Compliance Guidelines and Recommended Paths for Clinical Evaluation Paths for Certain Medical Devices, 25 July 2022. Address gaps in existing compliance requirements.

FDA

FDA Compliance COVID-19 Licensing

Health Care Compliance Brief

SQA Regulatory Surveillance Summary 3 | Monthly Update 2021

SQA Regulatory Surveillance Summary | Monthly Update 2022 – September/October

Webinars

Stay Connected